Bladder cancer natural history, complications and prognosis: Difference between revisions
Shanshan Cen (talk | contribs) |
Shanshan Cen (talk | contribs) No edit summary |
||
| Line 7: | Line 7: | ||
==Complications== | ==Complications== | ||
* [[ | * Common [[complications]] of bladder cancer include:<ref >Bladder Cancer. Medlineplus 2015.https://www.nlm.nih.gov/medlineplus/ency/article/000486.htm </ref> | ||
* [[Anemia]] | :* [[Metastasis]] | ||
* [[Hydronephrosis]] | :* [[Anemia]] | ||
* [[Urethral stricture]] | :* [[Hydronephrosis]] | ||
* [[Urinary incontinence]] | :* [[Urethral stricture]] | ||
:* [[Urinary incontinence]] | |||
==Prognosis== | ==Prognosis== | ||
Revision as of 13:03, 21 October 2015
|
Bladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bladder cancer natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Bladder cancer natural history, complications and prognosis |
|
FDA on Bladder cancer natural history, complications and prognosis |
|
CDC on Bladder cancer natural history, complications and prognosis |
|
Bladder cancer natural history, complications and prognosis in the news |
|
Blogs on Bladder cancer natural history, complications and prognosis |
|
Risk calculators and risk factors for Bladder cancer natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2] Shanshan Cen, M.D. [3]
Overview
Common complications of bladder cancer include metastasis, anemia, hydronephrosis, urethral stricture, and urinary incontinence. Prognosis is generally good, and the 5-year survival rate is approximately 77.4%. The prognosis varies with the stages of tumor; carcinoma in situ have the most favorable prognosis.
Complications
- Common complications of bladder cancer include:[1]
Prognosis
- Based on data from 2005-2011, the 5-year survival rate of patients with bladder cancer is approximately 77.4%.[2]
- Between 2004 and 2010, the 5-year relative survival of patients with bladder cancer was 79.1%.[3]
- When stratified by age, the 5-year relative survival of patients with bladder cancer was 83.8% and 74.1% for patients <65 and ≥ 65 years of age respectively.[3]
- The survival of patients with bladder cancer varies with the stage of the disease. Shown below is a table depicting the 5-year relative survival by the stage of bladder cancer:[3]
| Stage | 5-year relative survival (%), (2004-2010) |
| All stages | 77.4% |
| In situ | 96.2% |
| Localized | 69.2% |
| Regional | 33.7% |
| Distant | 5.5% |
| Unstaged | 48.7% |
- Shown below is an image depicting the 5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) between 2004 and 2010 of bladder cancer by stage at diagnosis according to SEER. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[3]
References
- ↑ Bladder Cancer. Medlineplus 2015.https://www.nlm.nih.gov/medlineplus/ency/article/000486.htm
- ↑ Bladder Cancer. Surveillance, Epidemiology, and End Results Program 2015.http://seer.cancer.gov/statfacts/html/urinb.html
- ↑ 3.0 3.1 3.2 3.3 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.